"USP 797 Training Requirements: A Case Study," Detailing Experiences at Swedish Medical Center/Seattle, Now Posted on PublicRelationsNewsroom.com
"USP 797 Training Requirements: A Case Study" published by Baxa Corporation is now posted for media and professional access on PublicRelationsNewsroom.com. This paper summarizes the process used by Swedish Medical Center in Seattle, WA to comply with the personnel training and evaluation in aseptic manipulation skills required by the United States Pharmacopeia (USP) Chapter 797.
Denver, CO, November 16, 2006 --(PR.com)-- Baxa Corporation’s "USP 797 Training Requirements: A Case Study" is now posted for media and professional access on PublicRelationsNewsroom.com. This paper summarizes the process used by Swedish Medical Center in Seattle, WA to comply with the personnel training and evaluation in aseptic manipulation skills required by the United States Pharmacopeia (USP) Chapter 797. “USP 797 Training Requirements: A Case Study” from Baxa Corporation is found at the following link: http://www.publicrelationsnewsroom.com/_wsn/page17.html.
USP Chapter 797 was released in January 2004, creating a new (US) national standard for sterile preparation. This standard is intended to describe the current best practice for quality assurance in sterile compounding in an effort to improve patient safety and reduce the number of adverse events related to sterile compounding activities.
The Joint Commission for Accreditation of Healthcare Organizations (JCAHO) has adopted these standards for use. Many individual State Pharmacy Boards are also including the standards in their inspections.
USP 797 is an evolving document that is subject to continuous refinement and updates. Refer to the USP Web site (www.usp.org) and the JCAHO Perspectives newsletter (www.jointcommission.org) for current guidance on the regulations. In addition to the new case study, the Baxa Corporation technical paper, “Understanding USP 797” is also found at the PR Newsroom site (http://www.publicrelationsnewsroom.com/_wsn/page4.html). This paper is authored by Baxa Corporation’s Michael Hurst RPh, MBA.
Baxa, a long-time proponent of hospital pharmacy safety initiatives recently launched its state-of-the-art STAR (Skills Training, Academics and Resources) Center for pharmacy and cleanroom skills training. Baxa designed and built the STAR Center as a fully USP 797-compliant pharmacy cleanroom to provide professional education on pharmacy practice, cleanroom principles and compliance to regulatory requirements.
The STAR Center, the only dedicated facility of its kind in the world for hands-on cleanroom experience and training in environmental monitoring and aseptic technique, provides a unique opportunity for industry professionals to learn best practice from subject-matter expert trainers. More information is available at http://www.baxa.com/starcenter.
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for fluid handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of fluid medications. Key products include Rapid-Fill™ Automated Syringe Fillers, Exacta-Med® Oral Dispensers, MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, and Exacta-Mix™ and MicroMacro™ Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg and The Netherlands; and distribution partners worldwide. Further information is available at http://www.baxa.com.
About Swedish Medical Center
Swedish is the largest, most comprehensive, nonprofit health provider in the Pacific Northwest. It is comprised of three hospital campuses (First Hill, Providence and Ballard), a new community-based emergency room and specialty center in Issaquah, Swedish Home Care Services and Swedish Physicians – a network of 12 primary-care clinics. In addition to general medical and surgical care, Swedish is known as a regional referral center, providing specialized treatment in areas such as cardiac care, oncology, orthopedics, high-risk obstetrics, neurological care, sleep medicine, pediatrics, organ transplantation and clinical research. For more information, visit http://www.swedish.org.
###
Contacts:
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
Email: marian.robinson@baxa.com
http://www.baxa.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations
303.984.9801, 303.669.3558 Email: maggie@absolutelypr.com
http://www.absolutelypr.com
USP Chapter 797 was released in January 2004, creating a new (US) national standard for sterile preparation. This standard is intended to describe the current best practice for quality assurance in sterile compounding in an effort to improve patient safety and reduce the number of adverse events related to sterile compounding activities.
The Joint Commission for Accreditation of Healthcare Organizations (JCAHO) has adopted these standards for use. Many individual State Pharmacy Boards are also including the standards in their inspections.
USP 797 is an evolving document that is subject to continuous refinement and updates. Refer to the USP Web site (www.usp.org) and the JCAHO Perspectives newsletter (www.jointcommission.org) for current guidance on the regulations. In addition to the new case study, the Baxa Corporation technical paper, “Understanding USP 797” is also found at the PR Newsroom site (http://www.publicrelationsnewsroom.com/_wsn/page4.html). This paper is authored by Baxa Corporation’s Michael Hurst RPh, MBA.
Baxa, a long-time proponent of hospital pharmacy safety initiatives recently launched its state-of-the-art STAR (Skills Training, Academics and Resources) Center for pharmacy and cleanroom skills training. Baxa designed and built the STAR Center as a fully USP 797-compliant pharmacy cleanroom to provide professional education on pharmacy practice, cleanroom principles and compliance to regulatory requirements.
The STAR Center, the only dedicated facility of its kind in the world for hands-on cleanroom experience and training in environmental monitoring and aseptic technique, provides a unique opportunity for industry professionals to learn best practice from subject-matter expert trainers. More information is available at http://www.baxa.com/starcenter.
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for fluid handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of fluid medications. Key products include Rapid-Fill™ Automated Syringe Fillers, Exacta-Med® Oral Dispensers, MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, and Exacta-Mix™ and MicroMacro™ Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg and The Netherlands; and distribution partners worldwide. Further information is available at http://www.baxa.com.
About Swedish Medical Center
Swedish is the largest, most comprehensive, nonprofit health provider in the Pacific Northwest. It is comprised of three hospital campuses (First Hill, Providence and Ballard), a new community-based emergency room and specialty center in Issaquah, Swedish Home Care Services and Swedish Physicians – a network of 12 primary-care clinics. In addition to general medical and surgical care, Swedish is known as a regional referral center, providing specialized treatment in areas such as cardiac care, oncology, orthopedics, high-risk obstetrics, neurological care, sleep medicine, pediatrics, organ transplantation and clinical research. For more information, visit http://www.swedish.org.
###
Contacts:
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
Email: marian.robinson@baxa.com
http://www.baxa.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations
303.984.9801, 303.669.3558 Email: maggie@absolutelypr.com
http://www.absolutelypr.com
Contact
Baxa Corporation
Maggie Chamberlin Holben, APR
303.984.9801 or 303.669.3558
http://www.baxa.com
Maggie Chamberlin Holben, APR
303.984.9801 or 303.669.3558
http://www.baxa.com
Contact
Categories